A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma

NCT00139659 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Diabetes Mellitus

Interventions

DRUG: Inhaled Insulin
DRUG: Subcutaneous Insulin

Sponsor

Pfizer